RHY
RHYTHM BIO FPO [RHY]
Healthcare · ASX Small Cap
$0.0820 +0.0%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when RHY triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is losing steam
- Stochastic is deep in oversold territory — bounce conditions forming
- Drifting lower — down 3.5% over the last 5 days
- Low cash runway (3 quarters) - dilution risk
- Revenue in sharp decline (-26%)
- Near 52-week low (3% of range)
- Small-cap ($20-100M)
- Sentiment is mixed — no strong consensus either way
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -26% — the top line is shrinking
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.44%/day)
Expected next for RHY
Window: 7 Oct to 21 Oct
The last 3 moved RHY -0.7% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE Initial Director's Interest Notice - Carl Stubbings
NONE Initial Director's Interest Notice - Maureen Baker
NONE FY26 Appendix 4E & Audited Financial Report
Announcement tone +3pts
Recent ASX Announcements
| 2026-08-28 | Initial Director's Interest Notice - Carl Stubbings |
| 2026-08-28 | Initial Director's Interest Notice - Maureen Baker |
| 2026-08-27 | FY26 Appendix 4E & Audited Financial Report PRICE SENSITIVE |
| 2026-08-25 | Appointment of Non-Executive Directors |
| 2026-08-21 | Notification of cessation of securities - RHY |
Key Metrics
$29.0M
Market Cap
218K
Avg Volume
0.8x
Vol Ratio
$0.07 — $0.28
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-276.0%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 72% |
| L | Leader vs Laggard | laggard | RS: -17 |
| I | Institutional Sponsorship | weak | Inst: 10% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track RHY and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required